{"altmetric_id": 84279743, "counts": {"readers": {"citeulike": "0", "mendeley": "84", "connotea": "0"}, "total": {"posts_count": 46}, "twitter": {"unique_users_count": 33, "posts_count": 43}, "news": {"unique_users_count": 2, "unique_users": ["the_medical_news", "chemical_engineering_news"], "posts_count": 2}, "blogs": {"unique_users_count": 1, "unique_users": [60332], "posts_count": 1}}, "citation": {"altmetric_jid": "532721422a83ee84788b4567", "authors": ["Liu, Lihong", "Wang, Pengfei", "Nair, Manoj S.", "Yu, Jian", "Rapp, Micah", "Wang, Qian", "Luo, Yang", "Chan, Jasper F-W.", "Sahi, Vincent", "Figueroa, Amir", "Guo, Xinzheng V.", "Cerutti, Gabriele", "Bimela, Jude", "Gorman, Jason", "Zhou, Tongqing", "Chen, Zhiwei", "Yuen, Kwok-Yung", "Kwong, Peter D.", "Sodroski, Joseph G.", "Yin, Michael T.", "Sheng, Zizhang", "Huang, Yaoxing", "Shapiro, Lawrence", "Ho, David D."], "doi": "10.1101/2020.06.17.153486", "first_seen_on": "2020-06-18T23:19:37+00:00", "issns": [], "journal": "bioRxiv", "last_mentioned_on": 1605483098, "links": ["https://www.biorxiv.org/content/10.1101/2020.06.17.153486v1", "https://pubmed.ncbi.nlm.nih.gov/32587975/", "https://www.biorxiv.org/content/10.1101/2020.06.17.153486v2.full", "https://www.biorxiv.org/content/10.1101/2020.06.17.153486v2", "http://dx.doi.org/10.1101/2020.06.17.153486", "https://doi.org/10.1101/2020.06.17.153486"], "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/06/18/2020.06.17.153486.full.pdf", "pmid": "32587975", "publisher": "Cold Spring Harbor Laboratory", "title": "Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/ac60f274-2ba3-34ce-925a-190c51c4c775/"}, "altmetric_score": {"score": 40.98, "score_history": {"1y": 40.98, "6m": 0, "3m": 0, "1m": 0, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 40.98}, "context_for_score": {"all": {"total_number_of_other_articles": 17726748, "mean": 9.445381652743, "rank": 625377, "this_scored_higher_than_pct": 96, "this_scored_higher_than": 17102035, "rank_type": "exact", "sample_size": 17726748, "percentile": 96}, "similar_age_3m": {"total_number_of_other_articles": 296474, "mean": 19.350927184171, "rank": 20288, "this_scored_higher_than_pct": 93, "this_scored_higher_than": 276215, "rank_type": "exact", "sample_size": 296474, "percentile": 93}, "this_journal": {"total_number_of_other_articles": 121097, "mean": 13.896826147634, "rank": 6367, "this_scored_higher_than_pct": 94, "this_scored_higher_than": 114795, "rank_type": "exact", "sample_size": 121097, "percentile": 94}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 8932, "mean": 16.411931034483, "rank": 558, "this_scored_higher_than_pct": 93, "this_scored_higher_than": 8374, "rank_type": "exact", "sample_size": 8932, "percentile": 93}}}, "demographics": {"poster_types": {"member_of_the_public": 20, "researcher": 11, "practitioner": 1, "science_communicator": 1}, "users": {"twitter": {"cohorts": {"Members of the public": 20, "Scientists": 11, "Practitioners (doctors, other healthcare professionals)": 1, "Science communicators (journalists, bloggers, editors)": 1}}, "mendeley": {"by_status": {"Student  > Postgraduate": 4, "Professor > Associate Professor": 3, "Researcher": 24, "Student  > Master": 4, "Student  > Ph. D. Student": 12, "Professor": 5, "Student  > Bachelor": 4, "Student  > Doctoral Student": 2, "Other": 7, "Librarian": 4, "Unspecified": 2}, "by_discipline": {"Medicine and Dentistry": 16, "Pharmacology, Toxicology and Pharmaceutical Science": 2, "Unspecified": 2, "Chemical Engineering": 1, "Arts and Humanities": 1, "Engineering": 3, "Chemistry": 3, "Neuroscience": 1, "Economics, Econometrics and Finance": 1, "Immunology and Microbiology": 6, "Computer Science": 2, "Agricultural and Biological Sciences": 11, "Nursing and Health Professions": 1, "Business, Management and Accounting": 1, "Biochemistry, Genetics and Molecular Biology": 15}}}, "geo": {"twitter": {"US": 14, "GE": 1, "IL": 1, "JP": 1, "GB": 1, "NO": 1, "SE": 1, "DE": 1, "NL": 1}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1949132852"}, "tweet_id": "1273757222493990912"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "748908558066982916"}, "tweet_id": "1273757223358005249"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1273721869816918018"}, "tweet_id": "1273758312421396480"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "332618565"}, "tweet_id": "1273774732438114304"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "914018537823449088"}, "tweet_id": "1273782065515958272"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1244711417657376768"}, "tweet_id": "1273795127950151681"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1274049975597449217"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "933631363084967936"}, "tweet_id": "1274268618168119296"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "4886500403"}, "tweet_id": "1274273651374915586"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "732996079122288645"}, "tweet_id": "1274351133906132992"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1115808462284263424"}, "tweet_id": "1274500109330337792"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "2476533262"}, "tweet_id": "1274768423181070340"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "854226651944824832"}, "tweet_id": "1274782113531904007"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "16910141"}, "tweet_id": "1274788660139839488"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "931267967559585793"}, "tweet_id": "1277251621311963137"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "62409858"}, "tweet_id": "1277261926616240130"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1026267266206380032"}, "tweet_id": "1277263687582171143"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "952319776273166336"}, "tweet_id": "1277264713525727241"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "980771282517143553"}, "tweet_id": "1277268500202037249"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "980771282517143553"}, "tweet_id": "1277270823221542912"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "291743805"}, "tweet_id": "1277273409907556352"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "556575387"}, "tweet_id": "1277276788423524352"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "746051821404291072"}, "tweet_id": "1277298406856294400"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "2597497614"}, "tweet_id": "1277312525076496386"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "556575387"}, "tweet_id": "1277321745981214721"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "92194579"}, "tweet_id": "1277474793772724225"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1245550931829116930"}, "tweet_id": "1277483875703205889"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1105077118613028865"}, "tweet_id": "1277492233399349253"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "287146811"}, "tweet_id": "1277549571951013890"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "392656022"}, "tweet_id": "1277827257176936449"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1279971100680753154"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "44063937"}, "tweet_id": "1280164068935053316"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "32674626"}, "tweet_id": "1280188528421298176"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1284084881128067072"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1284084902712016900"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1284085618969063424"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "65683924"}, "tweet_id": "1284151725012606979"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1286995357487050752"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1286995379066724352"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1286996530260512768"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1234328983598030850"}, "tweet_id": "1324382360813461504"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1234328983598030850"}, "tweet_id": "1328117721964285954"}, {"license": "gnip", "citation_ids": [84279743], "author": {"tweeter_id": "1234328983598030850"}, "tweet_id": "1328118491702968320"}], "news": [{"title": "Promising candidate monoclonal antibodies show \"exquisite potency\" against SAR-CoV-2", "url": "http://ct.moreover.com/?a=42417872348&p=1pl&v=1&x=JTfVLEYiMv0AxeAYYtiVOw", "license": "public", "citation_ids": [84279743], "posted_on": "2020-06-21T22:42:05+00:00", "summary": "Researchers at Columbia University, Dana-Farber Cancer Institute, and the National Institutes of Health have identified and characterized a range of monoclonal antibodies that potently neutralize severe acute respiratory syndrome coronavirus 2 (SARS-C\u2026", "author": {"name": "The Medical News", "url": "http://www.news-medical.net/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/146/normal/image.png?1369927508"}}, {"title": "Cryo-electron microscopy reaches resolution milestone", "url": "http://ct.moreover.com/?a=43176189058&p=1pl&v=1&x=2R_wGiVIFC1Gv9snq7YuIw", "license": "public", "citation_ids": [82581001, 82552102, 61052705, 73311841, 81024643, 83468871, 84279743, 68218931, 88497380], "posted_on": "2020-09-27T10:28:36+00:00", "summary": "Detailed protein structures are fueling drug-discovery efforts \u201cIt\u2019s like a miracle compared to a few years ago,\u201d says Bridget Carragher, codirector of the Simons Electron Microscopy Center at the New York Structural Biology Center, a research\u2026", "author": {"name": "Chemical & Engineering News", "url": "http://cen.acs.org/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/095/normal/C_ENNameplate.jpg?1561999883"}}], "blogs": [{"title": "Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology", "url": "https://www.cell.com/cell/fulltext/S0092-8674(20)31234-4?rss=yes", "license": "public", "citation_ids": [94064911, 94058534, 77720099, 78284411, 88386380, 84279743, 94018867, 94059428, 82125287, 83673704, 72860025, 85642566, 81898802, 85246037, 90396209, 90396209], "posted_on": "2020-09-16T00:00:00+00:00", "summary": "Serological analyses of \u223c650 SARS-CoV-2-exposed individuals show that 90% of the serum or plasma neutralizing activity targets the virus receptor-binding domain, with structural insights revealing how distinct types of neutralizing antibodies targeting the", "author": {"name": "Cell", "url": "http://www.cell.com/cell/current", "description": "Cell RSS feed. For more than 30 years, top international researchers have relied on Cell to publish high impact papers that have come to form the foundation of contemporary life science research.  Founded by Benjamin Lewin (author of Genes), Cell remains at the forefront of exciting developments in biology, continually redefining the important areas of science with cutting edge papers. Published biweekly, Cell includes original research articles of exceptional significance in areas including molecular biology, biochemistry, cancer research, cell biology, developmental biology, genetics, immunology, microbiology, neurobiology, plant biology, structural biology and virology. Submitted articles are reviewed rapidly for both technical quality and general interest, and, if accepted, are published within eight weeks. Cell features topical minireview and review articles in which noted scientists discuss current progress in all areas of the life sciences. Cell also publishes commentaries, meeting reviews, letters to the editor, and book reviews, as well as Positions Available and listings of Conferences and Courses.Visit the Cell website to find out more -  http://www.cell.com."}}]}, "score": 40.98, "images": {"small": "https://badges.altmetric.com/?size=64&score=41&types=mbtttttt", "medium": "https://badges.altmetric.com/?size=100&score=41&types=mbtttttt", "large": "https://badges.altmetric.com/?size=180&score=41&types=mbtttttt"}}